Evidence map›Paper›PMID 40723378›Full record

ArticleBiology2025

Development of a Lentiviral Reporter System for In Vitro Reprogramming of Astrocytes to Neuronal Precursors.

Anna Schnaubelt, Guoli Zheng, Maryam Hatami, Johannes Tödt, Hao Wang, Thomas Skutella, Andreas Unterberg, Klaus Zweckberger, Alexander Younsi

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna SchnaubeltDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Guoli ZhengDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.ORCID 0000-0002-7875-6006
Maryam HatamiMedical Faculty, University of Heidelberg, 69120 Heidelberg, Germany.
Johannes TödtDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Hao WangDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Thomas SkutellaMedical Faculty, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0003-4813-1213
Andreas UnterbergDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Klaus ZweckbergerDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Alexander YounsiDepartment of Neurosurgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.ORCID 0000-0002-8218-9243

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocytes, which proliferate after brain injury, represent a promising target for cellular reprogramming due to their abundance and ability to support brain repair. In this study, we investigated the in vitro reprogramming of primary cortical astrocytes from neonatal rats into neuronal precursor cells (NPCs) using the transcription factors Oct4, Sox2, and Klf4 (OSK), delivered via lentiviral vectors. We designed a reporter system to trace the conversion of astrocytes to NPCs and neurons by using GFAP-driven iCre and Nestin- or Synapsin1-driven fluorescent reporters. After transduction, we observed morphological changes and the expression of neuronal markers in some cells, while many cells remained in a transitional state, expressing both astrocytic and neuronal features. Importantly, the study was not designed to quantify reprogramming efficiency or demonstrate full astrocyte-to-neuron conversion but rather to establish and evaluate a traceable reporter system. Our data suggest that OSK-mediated reprogramming in this in vitro model can initiate conversion of astrocytes to neuronal precursor-like cells, although the process is complex and incomplete within the one-week timeframe. We also highlight limitations in co-transduction efficiency and potential silencing of the reporter system during reprogramming. These findings provide an initial technical platform to explore astrocyte reprogramming in vitro and inform future studies aiming to refine these methods and apply them in vivo.

Indexed as

astrocyte reprogrammingbrain repairKlf4lentiviral vectorsneuronal precursor cellsneuron conversionneuroregenerationOct4Sox2

Identifiers

PMID40723378
PMCPMC12292243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.